Sat.Oct 19, 2024 - Fri.Oct 25, 2024

article thumbnail

Pharmacists asked to help shape NHS 10-year plan

The Pharmacist

Pharmacists, other health professionals and the general public have been invited to respond to a national 'engagement exercise' to help shape the government's 10-year plan for the NHS. Prime Minister Sir Keir Starmer said today that while the government has 'a clear plan to fix the health service', it was 'only right that we hear […] The post Pharmacists asked to help shape NHS 10-year plan appeared first on The Pharmacist.

91
article thumbnail

Opinion: ‘Do no harm’ is hurting 400 million long Covid patients worldwide

STAT

Imagine, for a moment, that you wake up one morning with a debilitating illness that won’t let go. Weeks and months pass, but the crushing fatigue, constant headaches, and aching muscles remain. You can’t think straight. Simply showering or doing the dishes leaves you floored for days at a time, and the unpredictable symptoms — shortness of breath, dizziness, a racing heart — ebb and flow without warning.

363
363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dengue is spreading and Sanofi is pulling the market’s only vaccine. What’s next?

PharmaVoice

As Sanofi prepares to halt production on its dengue vaccine in 2026, locally acquired infections in the U.S. are raising the alarm.

Vaccines 246
article thumbnail

SAEM Clinical Images Series: When Needles Go Beyond Sewing and Acupuncture

ALiEM - Pharm Pearls

A 64-year-old male with a history of bipolar 1 disorder, PTSD, anxiety, depression, obsessive-compulsive disorder, GERD, and HTN presented to the ED with the chief complaint of foreign body and self-injury. He reported years of sticking sewing needles into his right arm, most recently yesterday. He explained that inserting needles makes him feel better with mild associated pain.

Vaccines 177
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

NICE recommendation for new Alexion PNH treatment

Pharma Times

danicopan shown to improve haemoglobin levels and reduce anaemia

143
143
article thumbnail

STAT+: For the behemoth UnitedHealth, a new threat to Medicare profits

STAT

For the nation’s largest health insurer, the evidence of abuse was stunning and unmistakable: UnitedHealth Group reaped billions from the federal Medicare program by diagnosing patients with serious chronic illnesses, and then delivering no follow-up care. The findings in the federal report reveal that UnitedHealth repeatedly sent clinicians into patients’ homes and pored over their medical charts to add diagnoses for illnesses such as vascular disease, heart failure, and diabetes.

Diabetes 359

More Trending

article thumbnail

SAEM Clinical Images Series: Not Your Average Ear Infection

ALiEM - Pharm Pearls

A 5-year-old generally healthy fully immunized boy presented to the ED with worsening left ear redness, swelling, and tenderness that his family noticed the day before presentation. His family had also recently noticed an abrasion over that ear. The patient was on amoxicillin for strep throat, which was diagnosed a week before the onset of his symptoms and was improving.

article thumbnail

RNA editing: emerging from CRISPR’s shadow

BioPharma Dive

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

141
141
article thumbnail

STAT+: UnitedHealth was top insurer collecting billions in questionable Medicare payments, federal watchdog finds

STAT

A federal watchdog found that Medicare Advantage insurers collected billions of dollars in dubious payments from Medicare in a single year by using home visits and medical chart reviews to diagnose patients with conditions for which they received no follow-up care.    A report released Thursday by the Office of Inspector General for the Health and Human Services Department concluded that insurers collectively received an estimated $7.5 billion in payments last year from so-called

article thumbnail

2024 PharmaVoice 100s: Patient Champions

PharmaVoice

Leaders advancing health advocacy, DEI initiatives and better medicine access for patients.

189
189
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Trick of the Trade: Cut IV extension tubing for 2-person ultrasound guided nerve block

ALiEM - Pharm Pearls

Ultrasound-guided procedures are difficult enough just identifying the anatomy. Performing a nerve block with the ultrasound in one hand and the needle in the other hand adds extra challenges. The simplest 1-person approach involves attaching a syringe with local anesthetic directly to the end of the procedural needle. A 2-person approach involves attach the syringe to a custom tubing-needle setup such as below.

141
141
article thumbnail

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

The Guardian - Pharmaceutical Industry

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly AstraZeneca has said it may cut jobs at its UK operation if the government enforces a global push to make companies share profits derived from nature’s genetic codes, multiple sources have told the Guardian. The alleged comments from the company came amid a concerted lobbying push by the pharmaceutical industry against the profit-sharing measures.

131
131
article thumbnail

Drinking is cheaper than it’s been in decades. Lobbyists are fighting to keep it that way

STAT

For years, it has been a reliable way to cut back on the consumption of cigarettes and sugary drinks: raise taxes on them. So it might seem an obvious tactic to apply to alcohol, which contributes to untold injuries, diseases and deaths in the United States each year. That’s the thinking of advocates and state legislators across the country, who also see it as a way to pull in more revenue.

Hospitals 353
article thumbnail

Why pharma megamergers may become a relic of the past

PharmaVoice

Despite pent up M&A demand, FTC scrutiny has had a chilling effect on pharma’s appetite for striking major deals.

173
173
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug

Pharma Times

CAL101 shows promising results and is set to enter phase 2 development

123
123
article thumbnail

Rise of almost untreatable superbug linked to a common antibiotic

The Guardian - Pharmaceutical Industry

‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led study has found.

126
126
article thumbnail

STAT+: Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study

STAT

Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes, an analysis of medical records found, supporting the case for further research of the blockbuster GLP-1 drug in neurodegenerative diseases. Among the over 1 million people with diabetes whose records were included in the study, the overall risk of developing Alzheimer’s was already very low.

Diabetes 343
article thumbnail

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

PharmaVoice

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Gilead, MSD say HIV combo could be weekly, oral HIV drug

pharmaphorum

An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024

121
121
article thumbnail

Intellia data spark debate about CRISPR drug’s potential

BioPharma Dive

Newly published data show the therapy reduced the rate of swelling attacks in people with hereditary angioedema, but didn't silence questions about its commercial outlook.

119
119
article thumbnail

Dietary experts advise skipping guidelines on ultra-processed foods — for now

STAT

If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with advising federal officials drafting the 2025-2030 Dietary Guidelines for Americans said the data were far too limited to draw conclusions. Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture.

339
339
article thumbnail

With activist investment rising, Pfizer’s battle with Starboard reflects the industry’s post-pandemic tumble

PharmaVoice

Pfizer’s proxy battle with Starboard has gotten messy. It’s the latest in a series of activist investor campaigns that have been on the rise in recent years.

147
147
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

UK launches scheme to boost dementia trial participation

pharmaphorum

UK scheme to tackle "historically low" numbers of people taking part in dementia trials launches with £20m in government funding

117
117
article thumbnail

Editas, changing course again, looks to partner lead CRISPR therapy

BioPharma Dive

The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for its clinical-stage treatment reni-cel.

118
118
article thumbnail

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years.

article thumbnail

How AI can manage the risks and costs of postmarketing requirements

PharmaVoice

PMRs are not new but drug developers can use AI to predict risk and manage costs earlier in studies.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pharma companies must adapt to keep pace with AI developments, say experts

Pharmaceutical Technology

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

115
115
article thumbnail

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

pharmaphorum

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

article thumbnail

Ability to wed: When getting married could mean losing lifesaving medical benefits

STAT

When Chelsea Smith met Jason Martin she knew right away that he was the one — so she refused to get his phone number. That’s because getting married would make Smith ineligible for Social Security benefits and Medicaid — financial support that she and many others with disabilities need to survive. Smith didn’t want to risk falling in love knowing she couldn’t get married.

325
325
article thumbnail

NICE recommends Santen’s Roclanda to treat glaucoma and ocular hypertension

Pharma Times

Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK

114
114
article thumbnail

Pharmacies piloting access to GP records

The Pharmacist

IT suppliers are testing pharmacy access to GP records with some pharmacies using Cegedim Rx live in a pilot stage, it has been revealed. Speaking at the Pharmacy Show earlier this month, Tahmina Rokib, clinical lead at the clinical digital informatics, transformation directorate at NHS England (NHSE) said that Cegedim had been running a pilot […] The post Pharmacies piloting access to GP records appeared first on The Pharmacist.

114
114